The main Xarelto patent expired this February
However, long-term safety data in healthy populations remains limited
And at best it actually improves cardiovascular event and death rate and slows down kidney progression
This activation increases insulin secretion in response to elevated blood glucose, suppresses glucagon release, and slows gastric emptying , leading to stabilized blood sugar levels and improved metabolic function
Patients who experience gastrointestinal side effects may require slower dose escalation, which delays reaching therapeutic doses but does not prevent eventual weight loss success
If GI side effects appear, depending upon the severity of GI events, either dose can be reduced or maintained or treatment can be stopped for some time and started again after a few days